1. Resident Memory T Cells in Autoimmune Skin Diseases.
- Author
-
Ryan GE, Harris JE, and Richmond JM
- Subjects
- Autoantigens immunology, Autoimmune Diseases drug therapy, Autoimmune Diseases genetics, Autoimmune Diseases pathology, CD4-Positive T-Lymphocytes drug effects, CD8-Positive T-Lymphocytes drug effects, Humans, Immunologic Factors pharmacology, Immunologic Memory drug effects, Immunologic Memory genetics, Skin immunology, Skin pathology, Skin Diseases drug therapy, Skin Diseases genetics, Skin Diseases pathology, Autoimmune Diseases immunology, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Immunologic Factors therapeutic use, Skin Diseases immunology
- Abstract
Tissue resident memory T cells (TRM) are a critical component of the immune system, providing the body with an immediate and highly specific response against pathogens re-infecting peripheral tissues. More recently, however, it has been demonstrated that TRM cells also form during autoimmunity. TRM mediated autoimmune diseases are particularly destructive, because unlike foreign antigens, the self-antigens are never cleared, continuously activating self-reactive TRM T cells. In this article, we will focus on how TRMs mediate disease in autoimmune skin conditions, specifically vitiligo, psoriasis, cutaneous lupus erythematosus, alopecia areata and frontal fibrosing alopecia., Competing Interests: JH is the founder of Villaris Therapeutics and NIRA Biosciences. JH and JR are inventors on patent application #62489191, “Diagnosis and Treatment of Vitiligo” which covers targeting IL-15 and TRM for the treatment of vitiligo; and on patent application #15/851,651, “Anti-human CXCR3 antibodies for the Treatment of Vitiligo” which covers targeting CXCR3 for the treatment of vitiligo. JR is a reviewer for Frontiers Immunology journal., (Copyright © 2021 Ryan, Harris and Richmond.)
- Published
- 2021
- Full Text
- View/download PDF